참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 7-(3-Chloropropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione | HCID 76011 | — |
| 반응물 | 4-(4-Fluorobenzoyl)piperidine | HCID 2724440 | — |
| 생성물 | Fluprophylline | HCID 65636 | 43.5% |
반응 단계
10.2 g 4-(p-fluorobenzoyl)-piperidine and 16.5 g 7-(chloropropyl)-theophylline are carefully mixed in the solid state and heated to 100° C. in a round flask in an oil bath. The mixture at first results in a clear melt, subsequently begins to crystallize and then changes into a solid mass. It is allowed to cool after 10 minutes, dissolved in ethyl acetate and 2n hydrochloric acid is added, whereby a dark oil separates in the organic phase, crystallizing on standing overnight. By recrystallizaing with 100 ml carbon tetrachloride, an intially oily then crystallizing substance is obtained, 7.4 g of the product with an mp of 114° to 119° C. (yield: 43.5%)
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04603204 |
|---|
| 출처 데이터셋 | uspto-grants-1986_07 |
|---|
| ORD ID | ord-46fa03f011a9453eb7129e6b18ed5bdc |
|---|
| 출처 메모 | uspto-grants-1986_07 |
|---|